A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer
-
Authors
-
-
Dittrich, Christian
-
Papai-Szekely, Zsolt
-
Vinolas, Nuria
-
Sederholm, Christer
-
Hartmann, Joerg T.
-
Behringer, Dirk
-
Kazeem, Gbenga
-
Desaiah, Durisala
-
Leschinger, Monika I.
-
von Pawel, Joachim1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- Type
- Published Article
- Journal
-
European Journal of Cancer
- Publisher
-
Elsevier
- Publication Date
-
2014
- Identifiers
-
DOI: 10.1016/j.ejca.2014.03.007
- Source
-
Elsevier
- Keywords
-
- License
-
Unknown
Report this publication